Le Lézard
Classified in: Health
Subject: AWD

S. Manjula Jegasothy MD, Miami, FL, Wins Over a Decade of Top Doctor Awards from Castle Connolly


MIAMI, July 2, 2024 /PRNewswire/ -- Dr. Manjula Jegasothy, renowned Board-Certified Cosmetic Dermatologist, is the Founder and CEO of Miami Skin Institute, situated in upscale Coral Gables in Miami, Florida. With degrees from both Harvard and Yale Universities, Dr. Jegasothy has garnered the trust of patients, peers, and the national beauty press, as well as numerous awards yearly, for her technical skills, innovative techniques, and profound knowledge of skin biology.

Drawing from 25+ years of experience, Dr. Jegasothy continuously incorporates new "secret" protocols for her non-surgical aesthetic procedures?both injectables and laser treatments. She consistently delivers superior results with minimal recovery time. Her expertise is highly sought-after by elite patients worldwide and has earned her over a decade of Top Doctor awards from prestigious media outlets such as Castle Connolly and U.S. News & World Report.

Dr. Jegasothy frequently shares her expert knowledge at aesthetic medical conferences internationally. She advocates for a "natural look," employing a gentle technique for precision injecting and laser settings to customize procedures for each patient, ensuring that they enhance but preserve their inherent beauty.

Emphasizing early intervention, Dr. Jegasothy recommends starting skincare and low dose injectables in early adulthood to enhance individual features, then continuing on to middle and older age adding laser treatments to keep her patients from aging for decades. Her modern approach includes utilizing light Fraxel®, Viora®, and Ultherapy® treatments to smooth, tighten, and lift areas that traditional Botox® and filler alone cannot address, achieving improvement without increasingly high injectable doses. Regenerative skin and hair treatments utilizing growth factors and exosomes are her latest ingredients to becoming "ageless".

Additionally, Dr. Jegasothy's pioneering work extends to transformative Kybella® fat-dissolving body treatments, as well as Sculptra® body contouring and laser cellulite reduction, achieving excellent results without the risks of surgery.

Dr. Jegasothy's visionary approach and tireless pursuit of excellence at the Miami Skin Institute is not just redefining cosmetic dermatology; she's illuminating a path to timeless confidence and empowerment for her patients around the globe.

About Dr. Manjula Jegasothy:
Education and Training:

Miami Skin Institute
135 San Lorenzo Ave, PH 870
Coral Gables, FL 33146
Phone: (305) 569-0067
miamiskininstitute.com

SOURCE MIAMI SKIN INSTITUTE


These press releases may also interest you

at 16:15
Simulations Plus, Inc. ("Simulations Plus"), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, today reported financial results for its third...

at 16:15
Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 123,500 shares of Astria's common stock on July 1, 2024 under Astria's...

at 16:11
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer's disease."Alzheimer's disease is a...

at 16:05
McKesson Corporation today released its Impact Report for fiscal year 2024 (FY24), showcasing the company's ongoing commitment to its purpose of Advancing Health Outcomes for All®. The report demonstrates McKesson's continued progress in achieving...

at 16:05
Cerus Corporation today announced the appointment of Dean Gregory to its Board of Directors. Mr. Gregory has a 30+-year career as a leader in the global blood transfusion and cell therapy industry, with broad experience across commercialization,...

at 16:05
Penumbra, Inc. today announced that it will host a conference call to discuss financial results for the second quarter 2024 after market close on Tuesday, July 30, 2024 at 4:30 PM Eastern Time. A press release with second quarter 2024 financial...



News published on and distributed by: